DESIGN AND IN VITRO/IN VIVO EVALUATION OF EXTENDED RELEASE MATRIX TABLETS OF NATEGLINIDE
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2018, Vol 7, Issue 6
Abstract
Aim: Nateglinide is a quick acting anti-diabetic medication whose potent activity lasts for a short duration. One of the dangerous side effects of nateglinide administration is rapid hypoglycemia, a condition that needs to be monitored carefully to prevent unnecessary fatalities. The aim of the study was to develop a longer lasting and slower releasing formulation of nateglinide that could be administered just once daily. Methods: Matrix tablets of nateglinide were prepared in combination with the polymers hydroxypropylmethylcellulose (HPMC), eudragits, ethyl cellulose and polyethylene oxide and the formulated drug release patterns were evaluated using in vitro and in vivo studies. Conclusion: Of the seventeen formulated matrix tablets tested, only one formulation labelled HA-2 that contained 15% HPMC K4M demonstrated release profile we had aimed for. Further, swelling studies and scanning electron microscopic analysis confirmed the drug release mechanism of HA-2. The optimized formulation HA-2 was found to be stable at accelerated storage conditions for 3 months with respect to drug content and physical appearance. Mathematical analysis of the release kinetics of HA-2 indicated a coupling of diffusion and erosion mechanisms. In-vitro release studies and pharmacokinetic in vivo studies of HA-2 in rabbits confirmed the sustained drug release profile we had aimed for. Keywords: Hydroxypropylmethylcellulose, Matrix tablets, Nateglinide, Sustained release
Authors and Affiliations
Mohini Sihare
Keywords
Related Articles
- EP ID EP487319
- DOI -
- Views 112
- Downloads 0
Synthesis and characterization of non-thiazolidinedione PPAR-γ agonists
Based on the assumptions of QSAR studies performed on oximes and oximinoacetic acid derivatives, reduced CLogP value compounds P1 and P2 were designed. In the present work, laboratory synthesis of these compounds P1 and...
HELLP SYNDROME: A BRIEF REVIEW
HELLP is an abbreviation of hemolysis (H), elevated liver enzyme (EL), and low platelet count (LP) which is a serious complication in pregnancy and also described as a severe form of preeclampsia and which is also associ...
COMPARATIVE IN VITRO ANALYSIS OF PHYSICOCHEMICAL PROPERTIES OF SOME ACECLOFENAC GENERIC TABLETS MARKETED IN BANGLADESH
Aceclofenac is a non-steroidal anti-inflammatory drug analog of diclofenac and works by inhibiting the action of cyclooxygenase (COX) that is involved in the production of prostaglandin (PG) and accountable for pain, swe...
Association between Psychological Status and Dyspnea in Patients with Chronic Obstructive Pulmonary Disease
Background: Dyspnea together with anxiety and depression are the most common and important comorbidities in patients with chronic obstructive pulmonary disease. Anxiety and depression can potentiate the intensity of dysp...
HEREDITARY GINGIVAL FIBROMATOSIS- A RARE AUTOSOMAL DOMINANT DISORDER
Hereditary gingival fibromatosis is a rare autosomal dominant disorder occurring either as an isolated trait or as a manifestation of a systemic disorder or syndrome which is characterized by a generalized diffused invol...